Screener
Pfizer PFE Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 73.2%+1.1pp | 73.5%+1.2pp | 74.3%+2.4pp | 73.4%+5.7pp | 72.1%+13.9pp | |
| Valuation | ||||||
| Market capitalization | $142.54B+6.6% | $159.73B+11.1% | $141.57B-5.8% | $144.87B-11.7% | $138.21B-12.7% | |
| Price / sales | 2.2×+0.1× | 2.5×+0.2× | 2.3×-0.1× | 2.3×-0.4× | 2.2×-0.7× |
FAQ
- Where do Pfizer's ratios come from?
- Every ratio is computed from Pfizer's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
